194 related articles for article (PubMed ID: 25619415)
1. Pleural effusion formation in the course of myeloma.
Comert M; Gursoy S; Tobu M
Arch Bronconeumol; 2015 Aug; 51(8):418-9. PubMed ID: 25619415
[No Abstract] [Full Text] [Related]
2. Two cases of permanent indwelling catheter for long-term administration of intrapleural chemotherapy.
Lázaro Sierra J; Carrasco V; Cases E; Gómez Gonzalez C
Arch Bronconeumol; 2017 Oct; 53(10):590-591. PubMed ID: 28359605
[No Abstract] [Full Text] [Related]
3. Extramedullary Multiple Myeloma With Pleural Involvement: A Rare Clinical Entity.
Velasco-Álvarez D; Gorospe-Sarasúa L; Fra-Fernández S; Blanchard MJ
Arch Bronconeumol (Engl Ed); 2019 Jun; 55(6):333-334. PubMed ID: 30360996
[No Abstract] [Full Text] [Related]
4. [Pleural effusion in multiple myeloma].
Ballesteros del Río B; Barbón Fernández M; Muela Molinero A; Sánchez Real Linacero J
An Med Interna; 2007 Jun; 24(6):306-7. PubMed ID: 17944046
[No Abstract] [Full Text] [Related]
5. Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.
Witzens-Harig M; Waldherr R; Beimler J; Zeier M; Hansmann J; Ho AD; Goldschmidt H; Moehler T
Ann Hematol; 2007 Dec; 86(12):927-30. PubMed ID: 17605010
[No Abstract] [Full Text] [Related]
6. Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma.
Cavo M; Pantani L; Pezzi A; Petrucci MT; Patriarca F; Di Raimondo F; Marzocchi G; Galli M; Montefusco V; Zamagni E; Gamberi B; Tacchetti P; Brioli A; Palumbo A; Sonneveld P
Leukemia; 2015 Dec; 29(12):2429-31. PubMed ID: 26442610
[No Abstract] [Full Text] [Related]
7. Myelomatous pleural effusion.
Ghosh S; Gopal R; Advani SH
J Assoc Physicians India; 2006 Sep; 54():738-9. PubMed ID: 17212026
[TBL] [Abstract][Full Text] [Related]
8. Sequential kidney and allogeneic hematopoietic stem cell transplantation.
Tanase AD; Sinescu I; Baston C; Tacu D; Domnisor L; Stefan L; Ranete A; Lipan L; Craciun O; Manea I; Bumbea H; Ciurea SO
Am J Hematol; 2019 Oct; 94(10):E267-E270. PubMed ID: 31342545
[No Abstract] [Full Text] [Related]
9. The significance of free light chain measurements in the diagnosis of myelomatous pleural effusion.
Tsukamoto A; Yoshiki Y; Yamazaki S; Kumano K; Nakamura F; Kurokawa M
Ann Hematol; 2014 Mar; 93(3):507-8. PubMed ID: 23797638
[No Abstract] [Full Text] [Related]
10. [Partial recovery of kidney function for an autologous transplant in a patient with chronic kidney disease and multiple myeloma].
de Alarcón Jiménez RM; Roca Meroño S; Alvarez Fernández GM; García Hernández MA; Navarro Parreño MJ; Jimeno Griñó C; Zarco Pedrinaci E; Molina Núñez M
Nefrologia; 2011; 31(2):238-40. PubMed ID: 21461027
[No Abstract] [Full Text] [Related]
11. Oligoclonal reconstitution masquerading as myeloma relapse.
Chim CS; Chan EY
Ann Hematol; 2013 Jun; 92(6):847-8. PubMed ID: 23150202
[No Abstract] [Full Text] [Related]
12. Myeloma presenting during pregnancy.
Smith D; Stevens J; Quinn J; Cavenagh J; Ingram W; Yong K
Hematol Oncol; 2014 Mar; 32(1):52-5. PubMed ID: 23996410
[No Abstract] [Full Text] [Related]
13. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Lemoli RM; Cavo M; Fortuna A
J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
[TBL] [Abstract][Full Text] [Related]
14. Tandem transplants in the treatment of multiple myeloma. Pro.
Fassas AB; Tricot G
Clin Adv Hematol Oncol; 2004 May; 2(5):303-4. PubMed ID: 17682284
[No Abstract] [Full Text] [Related]
15. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR
Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252
[TBL] [Abstract][Full Text] [Related]
16. Myelomatous pleural effusion in multiple myeloma- A rare presentation.
Pradeep IY; Mayuri RK; Sourabh SP; Nirali MP
J Cancer Res Ther; 2024 Jan; 20(1):476-478. PubMed ID: 38554369
[TBL] [Abstract][Full Text] [Related]
17. A phase 2 study of bortezomib, cyclophosphamide, pegylated liposomal doxorubicin and dexamethasone for newly diagnosed multiple myeloma.
Becker PS; Gooley TA; Green DJ; Burwick N; Kim TY; Kojouri K; Inoue Y; Moore DJ; Nelli E; Dennie T; Bensinger WI
Blood Cancer J; 2016 May; 6(5):e422. PubMed ID: 27176798
[No Abstract] [Full Text] [Related]
18. Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.
Cavo M; Tacchetti P; Patriarca F; Petrucci MT; Pantani L; Galli M; Di Raimondo F; Crippa C; Zamagni E; Palumbo A; Offidani M; Corradini P; Narni F; Spadano A; Pescosta N; Deliliers GL; Ledda A; Cellini C; Caravita T; Tosi P; Baccarani M;
Lancet; 2010 Dec; 376(9758):2075-85. PubMed ID: 21146205
[TBL] [Abstract][Full Text] [Related]
19. [Plasmocytic pleural effusion disclosing multiple myeloma].
Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
[TBL] [Abstract][Full Text] [Related]
20. DKK1 correlates with response and predicts rapid relapse after autologous stem cell transplantation in multiple myeloma.
Lemaire O; Attal M; Bourin P; Laroche M
Eur J Haematol; 2010 Mar; 84(3):276-7. PubMed ID: 19891699
[No Abstract] [Full Text] [Related]
[Next] [New Search]
